Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Insmed Inc.

Start price
Target price
Perf. (%)
€25.40
07.04.24
€15.00
30.09.25
-7.09%
13.05.24

Could be very worthwhile Investment >20% year
Peloton Interactive Inc.

Start price
Target price
Perf. (%)
€3.76
07.05.24
€5.00
11.03.25
7.19%
13.05.24

High valuation
Low dividend yield expected
negative Cash Flow expected
Bad rating
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.28
27.04.24
€2.00
27.04.25
3.55%
13.05.24

Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Nextera Energy Inc.

Start price
Target price
Perf. (%)
€64.66
03.05.24
€66.00
03.05.25
5.32%
13.05.24

Differentiated customer and product portfolio
Growths faster than the competition
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.40
04.02.24
€20.00
30.11.25
-77.89%
13.05.24

Could be very worthwhile Investment >20% year
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€2.47
02.05.24
€4.50
02.05.25
-16.88%
13.05.24

Could be very worthwhile Investment >20% year
buy
Heartland Express Inc.

Start price
Target price
Perf. (%)
€10.20
03.05.24
€18.00
03.05.25
5.88%
13.05.24

Could be very worthwhile Investment >20% year
buy
Mercedes-Benz Group AG

Start price
Target price
Perf. (%)
€68.13
10.05.24
€79.00
10.05.25
-0.54%
13.05.24

Could be worthwhile Investment >10% per year
buy
Mercedes-Benz Group AG

Start price
Target price
Perf. (%)
€68.13
10.05.24
€79.00
10.05.25
-0.54%
13.05.24

Could be worthwhile Investment >10% per year
buy
Altimmune

Start price
Target price
Perf. (%)
€5.09
12.12.23
-
12.12.24
30.56%
13.05.24

Could be worthwhile Investment >10% per year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€43.80
26.12.23
-
26.12.24
32.42%
13.05.24

Could be very worthwhile Investment >20% year
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€1.99
07.01.24
-
07.01.25
22.24%
13.05.24

Could be worthwhile Investment >10% per year
buy
O'Reilly Automotive Inc.

Start price
Target price
Perf. (%)
€881.20
12.05.23
€915.90
12.05.24
6.95%
13.05.24

buy
O'Reilly Automotive Inc.

Start price
Target price
Perf. (%)
€881.20
12.05.23
€915.90
12.05.24
6.95%
13.05.24

buy
O'Reilly Automotive Inc.

Start price
Target price
Perf. (%)
€881.20
12.05.23
€915.90
12.05.24
6.95%
13.05.24

buy
Stantec Inc.

Start price
Target price
Perf. (%)
€54.00
12.05.23
-
12.05.24
37.04%
13.05.24

buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€418.10
03.05.24
€425.00
03.05.25
5.41%
12.05.24

Market Leader or Top 3
Revenue growth >5% per year expected
Good rating
Some uniques
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€418.10
03.05.24
€425.00
03.05.25
5.41%
12.05.24

Market Leader or Top 3
Revenue growth >5% per year expected
Good rating
Some uniques
buy
Meta Platforms Inc.

Start price
Target price
Perf. (%)
€418.10
03.05.24
€425.00
03.05.25
5.41%
12.05.24

Market Leader or Top 3
Revenue growth >5% per year expected
Good rating
Some uniques
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€4.37
10.05.24
-
10.05.25
-27.99%
12.05.24

Risky Investment
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
5.58%
12.05.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
5.58%
12.05.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€194.35
27.04.24
€200.00
27.04.25
5.58%
12.05.24

Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
buy
Vonovia SE

Start price
Target price
Perf. (%)
€25.86
27.04.24
€27.00
27.04.25
7.19%
12.05.24

Could be worthwhile Investment >10% per year
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
buy
TeamViewer AG

Start price
Target price
Perf. (%)
€14.93
07.02.24
€16.00
07.02.25
-21.34%
12.05.24

Innovative
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected